CLINICAL TRIALS CTR
| Researcher : Karlberg JPE |
| List of Research Outputs |
| Karlberg J.P.E., Asian Clinical Trial Trends by Type of Sponsor, Trial Phase, Disease Area and Country, Clinical Trial Magnifier. 2011, 4(2): 53-68. |
| Karlberg J.P.E., Clinical Trials Overseen by US FDA., Clinical Trial Magnifier. 2010, 3(4): 279-297. |
| Karlberg J.P.E., Editorial: Easter celebration, Clinical Trial Magnifier. 2011, 4(2): 46-47. |
| Karlberg J.P.E., Editorial: Something about nothing & Something about a new thing, Clinical Trial Magnifier. 2011, 4(1): 2-3. |
| Karlberg J.P.E., Editorial: The Life-Science Loop, Clinical Trial Magnifier. 2010, 3(6): 387-393. |
| Karlberg J.P.E., Yao T.J., Tam S.Y.M., Wong C.K.W., Wong S.W.S., Dubois J.E.A.N.-.D.E.N.I.S., Gluck S.T.E.F.A.N. and Tsuei E.D.M.U.N.D. .S., Investigators Incentives for Trial Participation (I-Incent) Report, Clinical Trial Magnifier. 2010, 3(6): 394-402. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC1 Study Termination/Close-out Visit, Clinical Trial Magnifier. 2010, 3(6): 439-442. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC2 Test Drug Destruction at Study Site, Clinical Trial Magnifier. 2010, 3(6): 443-445. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC3 Archiving of Study Data, Clinical Trial Magnifier. 2010, 3(6): 446-447. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC4 End-of-Trial Report, Clinical Trial Magnifier. 2010, 3(6): 448-449. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T11: Preparing and Managing Source Documents., Clinical Trial Magnifier. 2010, 3(4): 300-302. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T12: Records Retention., Clinical Trial Magnifier. 2010, 3(4): 303-305. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T13: Specimen Collection, Handling and Shipping. , Clinical Trial Magnifier. 2010, 3(4): 306-310. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T14: Continuing Review/Progress Reports and Communications with IRB, Clinical Trial Magnifier. 2010, 3(5): 347-349. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T15: Adverse Event and Serious Adverse Event Reporting , Clinical Trial Magnifier. 2010, 3(5): 350-353. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T16: Study Interim Data Analyses and Reports, Clinical Trial Magnifier. 2010, 3(5): 358-359. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T17: Data and Safety Monitoring Committee, Clinical Trial Magnifier. 2010, 3(5): 360-362. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T18: Protocol Deviations and Violations, Clinical Trial Magnifier. 2010, 3(5): 363-364. |
| Karlberg J.P.E., The Establishment of Emerging Trial Regions, Clinical Trial Magnifier. 2011, 4(1): 7-23. |
| Karlberg J.P.E., Who International Clinical Trials Registry Platform - An In-depth Analysis, Clinical Trial Magnifier. 2010, 3(5): 333-344. |
| Researcher : Tam S |
| List of Research Outputs |
| Ong K.L., Jiang C.Q., Liu B., Jin Y.L., Tso A.W.K., Tam S., Wong K.S., Tomlinson B., Cheung B.M.Y., Lin J.M., Yue X.J., Lam K.S.L., Lam T.H. and Thomas G.N., Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese, Clin Endocrinol (Oxf). 2010, 74: 206-13. |
| Researcher : Tam SYM |
| List of Research Outputs |
| Karlberg J.P.E., Yao T.J., Tam S.Y.M., Wong C.K.W., Wong S.W.S., Dubois J.E.A.N.-.D.E.N.I.S., Gluck S.T.E.F.A.N. and Tsuei E.D.M.U.N.D. .S., Investigators Incentives for Trial Participation (I-Incent) Report, Clinical Trial Magnifier. 2010, 3(6): 394-402. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC1 Study Termination/Close-out Visit, Clinical Trial Magnifier. 2010, 3(6): 439-442. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC2 Test Drug Destruction at Study Site, Clinical Trial Magnifier. 2010, 3(6): 443-445. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC3 Archiving of Study Data, Clinical Trial Magnifier. 2010, 3(6): 446-447. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP No: SC4 End-of-Trial Report, Clinical Trial Magnifier. 2010, 3(6): 448-449. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T11: Preparing and Managing Source Documents., Clinical Trial Magnifier. 2010, 3(4): 300-302. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T12: Records Retention., Clinical Trial Magnifier. 2010, 3(4): 303-305. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T13: Specimen Collection, Handling and Shipping. , Clinical Trial Magnifier. 2010, 3(4): 306-310. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T14: Continuing Review/Progress Reports and Communications with IRB, Clinical Trial Magnifier. 2010, 3(5): 347-349. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T15: Adverse Event and Serious Adverse Event Reporting , Clinical Trial Magnifier. 2010, 3(5): 350-353. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T16: Study Interim Data Analyses and Reports, Clinical Trial Magnifier. 2010, 3(5): 358-359. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T17: Data and Safety Monitoring Committee, Clinical Trial Magnifier. 2010, 3(5): 360-362. |
| Karlberg J.P.E. and Tam S.Y.M., Study Site Standard Operating Procedure SOP T18: Protocol Deviations and Violations, Clinical Trial Magnifier. 2010, 3(5): 363-364. |
| Researcher : Wong CKW |
| List of Research Outputs |
| Karlberg J.P.E., Yao T.J., Tam S.Y.M., Wong C.K.W., Wong S.W.S., Dubois J.E.A.N.-.D.E.N.I.S., Gluck S.T.E.F.A.N. and Tsuei E.D.M.U.N.D. .S., Investigators Incentives for Trial Participation (I-Incent) Report, Clinical Trial Magnifier. 2010, 3(6): 394-402. |
| Researcher : Wong SWS |
| List of Research Outputs |
| Karlberg J.P.E., Yao T.J., Tam S.Y.M., Wong C.K.W., Wong S.W.S., Dubois J.E.A.N.-.D.E.N.I.S., Gluck S.T.E.F.A.N. and Tsuei E.D.M.U.N.D. .S., Investigators Incentives for Trial Participation (I-Incent) Report, Clinical Trial Magnifier. 2010, 3(6): 394-402. |
| Researcher : Yao T |
| List of Research Outputs |
| Chan K.H., Yeung S.C., Yao T., Ip M.S.M., Cheung A.H.K., Chan M.M.W. and Mak J.C.W., Elevated Plasma Adiponectin Levels In Patients With Chronic Obstructive Pulmonary Disease, Internatioanl Journal Of Tuberculosis And Lung Disease. 2010, 14: 1193-1200. |
| Researcher : Yao TJ |
| List of Research Outputs |
| Karlberg J.P.E., Yao T.J., Tam S.Y.M., Wong C.K.W., Wong S.W.S., Dubois J.E.A.N.-.D.E.N.I.S., Gluck S.T.E.F.A.N. and Tsuei E.D.M.U.N.D. .S., Investigators Incentives for Trial Participation (I-Incent) Report, Clinical Trial Magnifier. 2010, 3(6): 394-402. |
| Yuen V.M.Y., Hui T.W.C., Irwin M.G., Yao T.J., Wong G.L.S. and Yuen M.K., Optimal timing for the administration of intranasal dexmedetomidine for premedication in children, Anaesthesia. 2010. |